Annual FCF:
-$184.46M-$27.73M(-17.70%)Summary
- As of today, XENE annual free cash flow is -$184.46 million, with the most recent change of -$27.73 million (-17.70%) on December 31, 2024.
- During the last 3 years, XENE annual free cash flow has fallen by -$112.91 million (-157.80%).
- XENE annual free cash flow is now -509.49% below its all-time high of $45.05 million, reached on December 31, 2012.
Performance
XENE Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
-$66.69M-$5.00M(-8.10%)Summary
- As of today, XENE quarterly free cash flow is -$66.69 million, with the most recent change of -$5.00 million (-8.10%) on June 1, 2025.
- Over the past year, XENE quarterly free cash flow has dropped by -$34.59 million (-107.72%).
- XENE quarterly free cash flow is now -445.58% below its all-time high of $19.30 million, reached on December 31, 2019.
Performance
XENE Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$232.08M-$34.59M(-17.51%)Summary
- As of today, XENE TTM free cash flow is -$232.08 million, with the most recent change of -$34.59 million (-17.51%) on June 1, 2025.
- Over the past year, XENE TTM free cash flow has dropped by -$76.25 million (-48.93%).
- XENE TTM free cash flow is now -9496.48% below its all-time high of $2.47 million, reached on September 30, 2014.
Performance
XENE TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
XENE Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -17.7% | -107.7% | -48.9% |
| 3Y3 Years | -157.8% | -286.2% | -224.9% |
| 5Y5 Years | -2998.2% | -517.8% | -1188.1% |
XENE Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -157.8% | at low | -124.2% | at low | -167.6% | at low |
| 5Y | 5-Year | -2998.2% | at low | -420.8% | at low | -1188.1% | at low |
| All-Time | All-Time | -509.5% | at low | -445.6% | at low | -9496.5% | at low |
XENE Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$66.69M(-8.1%) | -$232.08M(-17.5%) |
| Mar 2025 | - | -$61.70M(-18.8%) | -$197.50M(-8.4%) |
| Dec 2024 | -$184.46M(-17.7%) | -$51.91M(-0.3%) | -$182.18M(-11.1%) |
| Sep 2024 | - | -$51.78M(-61.3%) | -$163.96M(-5.2%) |
| Jun 2024 | - | -$32.11M(+30.8%) | -$155.83M(+2.2%) |
| Mar 2024 | - | -$46.38M(-37.6%) | -$159.34M(-6.5%) |
| Dec 2023 | -$156.73M(-50.8%) | -$33.69M(+22.8%) | -$149.58M(-1.5%) |
| Sep 2023 | - | -$43.66M(-22.6%) | -$147.39M(-10.4%) |
| Jun 2023 | - | -$35.61M(+2.8%) | -$133.48M(-15.9%) |
| Mar 2023 | - | -$36.62M(-16.2%) | -$115.14M(-18.5%) |
| Dec 2022 | -$103.92M(-45.2%) | -$31.51M(-5.9%) | -$97.16M(-12.0%) |
| Sep 2022 | - | -$29.75M(-72.3%) | -$86.71M(-21.4%) |
| Jun 2022 | - | -$17.27M(+7.4%) | -$71.43M(-4.0%) |
| Mar 2022 | - | -$18.64M(+11.5%) | -$68.69M(+3.5%) |
| Dec 2021 | -$71.55M(-41.0%) | -$21.06M(-45.6%) | -$71.16M(-9.4%) |
| Sep 2021 | - | -$14.46M(+0.5%) | -$65.04M(-2.6%) |
| Jun 2021 | - | -$14.53M(+31.2%) | -$63.38M(-6.3%) |
| Mar 2021 | - | -$21.11M(-41.4%) | -$59.65M(-14.2%) |
| Dec 2020 | -$50.76M(-752.6%) | -$14.93M(-16.6%) | -$52.25M(-190.0%) |
| Sep 2020 | - | -$12.81M(-18.6%) | -$18.02M(-43.4%) |
| Jun 2020 | - | -$10.80M(+21.3%) | -$12.57M(-18.4%) |
| Mar 2020 | - | -$13.71M(-171.1%) | -$10.61M(-79.8%) |
| Dec 2019 | -$5.95M | $19.30M(+362.3%) | -$5.90M(+81.8%) |
| Sep 2019 | - | -$7.36M(+16.8%) | -$32.39M(+15.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$8.84M(+1.8%) | -$38.49M(-9.4%) |
| Mar 2019 | - | -$9.00M(-25.2%) | -$35.18M(-1.7%) |
| Dec 2018 | -$35.23M(-21.3%) | -$7.19M(+46.6%) | -$34.58M(-2.0%) |
| Sep 2018 | - | -$13.46M(-143.2%) | -$33.91M(-12.3%) |
| Jun 2018 | - | -$5.53M(+34.1%) | -$30.19M(+4.0%) |
| Mar 2018 | - | -$8.40M(-28.8%) | -$31.45M(-6.1%) |
| Dec 2017 | -$29.04M(-46.3%) | -$6.52M(+33.1%) | -$29.65M(-8.1%) |
| Sep 2017 | - | -$9.74M(-43.3%) | -$27.43M(-23.7%) |
| Jun 2017 | - | -$6.80M(-3.0%) | -$22.18M(-4.2%) |
| Mar 2017 | - | -$6.60M(-53.5%) | -$21.28M(-8.0%) |
| Dec 2016 | -$19.85M(-6.4%) | -$4.30M(+4.3%) | -$19.71M(+4.4%) |
| Sep 2016 | - | -$4.49M(+23.8%) | -$20.61M(-0.1%) |
| Jun 2016 | - | -$5.89M(-17.2%) | -$20.59M(-19.3%) |
| Mar 2016 | - | -$5.03M(+3.4%) | -$17.27M(+3.4%) |
| Dec 2015 | -$18.65M(-1377.0%) | -$5.21M(-16.5%) | -$17.87M(-9.2%) |
| Sep 2015 | - | -$4.47M(-74.0%) | -$16.36M(-179.1%) |
| Jun 2015 | - | -$2.57M(+54.4%) | -$5.86M(-5.9%) |
| Mar 2015 | - | -$5.63M(-52.3%) | -$5.54M(-350.8%) |
| Dec 2014 | -$1.26M(+63.7%) | -$3.70M(-161.3%) | -$1.23M(-149.7%) |
| Sep 2014 | - | $6.03M(+369.1%) | $2.47M(+169.3%) |
| Jun 2014 | - | -$2.24M(-69.6%) | -$3.56M(-169.6%) |
| Mar 2014 | - | -$1.32M | -$1.32M |
| Dec 2013 | -$3.48M(-107.7%) | - | - |
| Dec 2012 | $45.05M(+422.2%) | - | - |
| Dec 2011 | -$13.98M | - | - |
FAQ
- What is Xenon Pharmaceuticals Inc. annual free cash flow?
- What is the all-time high annual free cash flow for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. annual free cash flow year-on-year change?
- What is Xenon Pharmaceuticals Inc. quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. quarterly free cash flow year-on-year change?
- What is Xenon Pharmaceuticals Inc. TTM free cash flow?
- What is the all-time high TTM free cash flow for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. TTM free cash flow year-on-year change?
What is Xenon Pharmaceuticals Inc. annual free cash flow?
The current annual free cash flow of XENE is -$184.46M
What is the all-time high annual free cash flow for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high annual free cash flow is $45.05M
What is Xenon Pharmaceuticals Inc. annual free cash flow year-on-year change?
Over the past year, XENE annual free cash flow has changed by -$27.73M (-17.70%)
What is Xenon Pharmaceuticals Inc. quarterly free cash flow?
The current quarterly free cash flow of XENE is -$66.69M
What is the all-time high quarterly free cash flow for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high quarterly free cash flow is $19.30M
What is Xenon Pharmaceuticals Inc. quarterly free cash flow year-on-year change?
Over the past year, XENE quarterly free cash flow has changed by -$34.59M (-107.72%)
What is Xenon Pharmaceuticals Inc. TTM free cash flow?
The current TTM free cash flow of XENE is -$232.08M
What is the all-time high TTM free cash flow for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high TTM free cash flow is $2.47M
What is Xenon Pharmaceuticals Inc. TTM free cash flow year-on-year change?
Over the past year, XENE TTM free cash flow has changed by -$76.25M (-48.93%)